Janus Henderson Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,500
Closed -$554K 2566
2024
Q2
$554K Buy
+20,500
New +$426K ﹤0.01% 1940
2023
Q4
Sell
-16,753
Closed -$251K 2622
2023
Q3
$251K Buy
16,753
+2
+0% +$42 ﹤0.01% 2275
2023
Q2
$544K Sell
16,751
-19
-0.1% -$694 ﹤0.01% 1932
2023
Q1
$656K Sell
16,770
-534,555
-97% -$26.1M ﹤0.01% 1872
2022
Q4
$29.1M Sell
551,325
-979,155
-64% -$47.7M 0.02% 489
2022
Q3
$68.9M Buy
1,530,480
+694,495
+83% +$29.9M 0.03% 445
2022
Q2
$30.4M Sell
835,985
-48,146
-5% -$1.75M 0.02% 498
2022
Q1
$36.5M Sell
884,131
-51,267
-5% -$1.8M 0.02% 586
2021
Q4
$39.9M Sell
935,398
-14,676
-2% -$734K 0.02% 622
2021
Q3
$52.3M Sell
950,074
-3,288
-0.3% -$172K 0.02% 539
2021
Q2
$45.6M Sell
953,362
-52
-0% -$2.65K 0.02% 593
2021
Q1
$48.3M Sell
953,414
-10,867
-1% -$604K 0.02% 563
2020
Q4
$60.7M Sell
964,281
-68,970
-7% -$4.28M 0.03% 490
2020
Q3
$69.4M Sell
1,033,251
-344,177
-25% -$18.8M 0.04% 412
2020
Q2
$57.7M Sell
1,377,428
-258,034
-16% -$9.91M 0.03% 452
2020
Q1
$51.5M Sell
1,635,462
-293,466
-15% -$11.7M 0.04% 450
2019
Q4
$77.9M Sell
1,928,928
-916,653
-32% -$32.1M 0.04% 455
2019
Q3
$88.6M Buy
2,845,581
+2,458,637
+635% +$98M 0.05% 408
2019
Q2
$18.8M Buy
+386,944
New +$16.5M 0.01% 809

Other funds holding SILK

Janus Henderson Group's SILK Position: Q3 2024 in Review

Janus Henderson Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 20,500 shares — an estimated $554K sold.

Janus Henderson Group first reported a position in SILK in Q2 2019 and held it in 19 quarters. The position peaked at $88.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Janus Henderson Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Janus Henderson Group sold 20,500 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $554K.
  • Janus Henderson Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • Janus Henderson Group's Silk Road Medical, Inc. Common Stock position peaked at $88.6M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.